A novel bacteriocin, plantaricin ZJ5 (PZJ5) was yielded from Lactobacillus plantarum ZJ5, cloned, and produced in Escherichia coli BL21 (DE3) pLys. The PZJ5 structural gene was fused with a Trx tag, and cloned into the pET32a plasmid under the control of the inducible lac operon. Induction was performed with isopropyl-β-D-thiogalactopyranoside (IPTG), with subsequent overexpression of the fusion protein, followed by purification to homogeneity via His affinity chromatography. Recombinant E. coli produced greater quantities of PZJ5 than L. plantarum ZJ5, and PZJ5 in E. coli was expressed in the form of soluble material. Biologically active PZJ5 was recovered by cleaving the purified fusion protein using enterokinase. The released PZJ5 demonstrated antibacterial activity against Micrococcus luteus. In this study, an inexpensive biological method using a Trx fusion system was presented, and for the first time, bacteriocin PZJ5 was expressed and purified in E. coli.
Bacteriocins are peptides synthesized in ribosomes, and can provide antibacterial action against bacteria that is closely related to the bacteria used to produce them. The relatively small bacteriocins formed by lactic acid bacteria (LAB) are predominantly heat-stable, cationic, and hydrophobic. This type of bacteriocin has therefore attracted a great deal of attention due to potential food preservation applications, such as preventing spoilage caused by pathogenic bacteria. Nonetheless, industrial application will require systems that can scale up production of the biologically active antimicrobial peptides to generate large enough quantities. The amphiphilic bacteriocin plantaricin ZJ5 (PZJ5) is an alpha-helical peptide produced by L. plantarum ZJ5, and is composed of 22 amino acids [1] . The inhibitory actions of PZJ5 are wide-ranging against both Gram-positive and Gram-negative bacteria, and can be maintained under extreme temperature and pH conditions. Moreover, the peptides are potent against Staphylococcus aureus. However, it is susceptible to digestion by pepsin and proteinase K. Therefore, a food-borne isolate of PZJ5 has been proposed as a promising candidate for probiotic applications.
Comprehensive genetic characterization of Escherichia coli (E.coli)
has led to its wide use as an prokaryotic host, with importance in cloning and expression of heterologous genes [2] . Many of its biological processes have been fully elucidated, and there are numerous genetic tools available to exploit these. Importantly, recombinant technologies have made use of E.coli, as well as the expression of a number of genes encoding the biosynthesis of a variety of antimicrobial peptides [3, 4] . Antimicrobial peptides, whole or partially purified, can be utilized as preservatives. In addition, they can be successfully applied to reduce the quantity of certain pathogens or to eliminate them completely. Nevertheless, the potential for production of these peptides is low, since isolation and purification using native hosts is a complicated, time intensive, and expensive process [1, 5] . In this study, we examine the heterologous expression of PZJ5 in E. coli. Based on the results, our production method is capable of producing large quantities of PZJ5 peptides for use in further studies.
After restricting the enzyme and performing nucleotide sequencing, plasmid profiling was carried out to verify the pET32a-PZJ5 was present. Digestion of pET32a-PZJ5 by Kpn I and Xho I was carried out, and ligation of the inserted mature PZJ5 sequence to the nucleotide sequence encoding the enterokinase recognition site was observed (data not shown). The size range of the expressed proteins was determined using SDS-PAGE (Figure 1 ). After IPTG induction, overexpression of Trx-His-tagged fusion protein PZJ5 in E. coli BL21 (pET32a-PZJ5) was observed (Fig. 1, lane 3) . Conversely, no expression was shown in induced controls, E. coli BL21 and E. coli BL21 (pET32a). The protein band was found to correspond to the combined molecular mass predicted for Trx-His17 kDa + PZJ5 2. Large quantities of PZJ5 are needed for industrial applications; therefore, we sought to find an appropriate method for the largescale production of PZJ5. A number of advantages can be attributed to heterologous expression compared to native systems, such as increased production levels of protein, which is pure and homogeneously labeled, and better control over gene expression [6] .
As a host, E. coli has been used to clone a variety of genes associated with bacteriocin biosynthesis. Bacteriocin-related genes including pediocin PA-1, divergicinV41, enterocin P, and gassericin A have previously been expressed in E. coli [7] [8] [9] [10] [11] that have been produced recombinantly, and has previously been employed for use with E.coli to express many biologically-active proteins.
The PZJ5 fusion peptide was purified using His Trap HP at a concentration of 1.66 mg/mL, and yields were generated at 4.2 mg per 1 g of the wet cell mass. The histidine tag was located between TRX and PZJ5, and facilitated selective immobilization of the TRX-(His) 6 -PZJ5 fusion protein on a nickel-chelation column. Increasing the imidazole concentration allowed specific elution of the protein. Toxicity of Trx-His-tagged fused PZJ5 (19.3 kDa) to the host cell was minimal in contrast to the more toxic and previously studied the recombinant production in E. coli BL21 (pET28) of His-tagged antimicrobial peptide [12, 13] . Moreover, we have shown here the stable expression Trx-His-tagged fused PZJ5 in E. coli BL21 (DE3). Since host toxicity is exceedingly important in the production of large amounts of target proteins in E. coli, in our study, Trx-His-fused PZJ5 appeared to be a well suited to this purpose ( Figure 2 ). Purified under native conditions, Trx-His-tagged fusion PZJ5 had a high yield and purity ( Table 1) . Most of the fusion protein was essentially accumulated as soluble material in the E. coli cytoplasm as evidenced in our results. The production and purification of antimicrobial peptide PZJ5 was previously reported by Song et al., in which four steps were used to purify native PZJ5 using ammonium sulfate precipitation, cation-exchange chromatography, hydrophobic-interaction chromatography, and reverse-phase HPLC [1] . A total of 123 μg of purified PZJ5 was recovered from 1 g of total protein. Therefore, the process of isolation and purification of antimicrobial peptides from native hosts is time-consuming and laborious.
The agar diffusion assay was used to assess the biological activity of recombinant PZJ5. Purified PZJ5 treated with enterokinase to get rid of the Trx-His fusion protein exhibited antibacterial activity against M. luteus, which indicates that enterokinase treatment successfully release the biologically active PZJ5 from the fusion protein ( Figure 3 ).
Bacteriocins are a class of small polypeptides that exhibit bactericidal activity against bacteria closely related to the bacteria that produce them. Among bacteriocins, biologically active PZJ5 is an extremely promising probiotic candidate due to its broad range of inhibitory actions and heat stability. Highly efficient production of large quantities of PZJ5 at low cost is necessary to enable use in both the laboratory and potential applications in the food industry. For the first time, we have described the heterologous expression and purification of bioactive PZJ5 by E.coli.
In this study, soluble expression levels were increased and toxicity was decreased using fusion expression, which is additionally capable of providing the purification tags required for our heterologous expression strategy. Our strategy may provide an important alternative method for the soluble expression of PZJ5. The proposed system to express and purify large quantities of PZJ5 will facilitate prospective laboratory-based investigations. In the near future, numerous biochemical and biological investigations could be made possible through the availability of purified PZJ5, leading to advances in food preservation technologies. 
Experimental
Bacterial strains and culture conditions: The strains of bacterial and plasmids used in this investigation are listed in Table 2 . The growth of E. coli DH5α (Clontech, Mountain View, CA, USA) and E. coli BL21 (DE3) (Novagen, Madison, WI, USA) was realized in LB medium in a shaking incubator at 37°C. To prepare agar plates, 1.5% agar was added to LB medium. Antibiotics (Sangon Biotech, Shanghai, China), used for selection purposes, were added at suitable concentrations (ampicillin, 100 μg/mL).
Gene synthesis and DNA amplification:
The amino acid sequence of PZJ5 was used to perform codon optimization of the gene for expression in E. coli. An upstream and downstream DNA primer Cloning and heterologous expression of plantaricin ZJ5 Natural Product Communications Vol. 13 (12) were designed and synthesized via the DNASTAR software (Madison, WI, USA). The upstream primer included cleavage sites for Kpn I and enterokinase and the downstream primer contained cleavage sites for Xho I. Synthesis of all PZJ5 gene fragments and primers was done in Sangon Biotech. The following primer sequences were used: PZJ5F: 5′-GGGGTACCGACGACGACGA CAAGAAGACTAAACAACAATTTTTAAT-3′ (Kpn I); PZJ5R: 5′-CCGCTCGAGTCATAATGTATAACCAAA-3′ (Xho I).
DNA was amplified using a Biometra T personal PCR System (Göettingen, Germany). The final reaction volume of each sample was 50 μL and the final MgCl 2 concentration was 1.5 mM. The following reagents and concentrations were used: dNTPs, 200 mM; primers, 1 μM; and Taq polymerase (Takara HiFi DNA polymerase, Takara Bio, Shiga, Japan), one unit per reaction. The thermal protocol was as follows: (1) Plasmid construction: The pET32a system was used to express the PZJ5 protein with Trx tand His tags (Table 1) . Briefly, the PZJ5F and PZJ5R primers were used to amplify the PZJ5 coding sequence, which was then cloned into pET32a, an expression vector. The pET32a-PZJ5 construct (Table 1) induced the expression of TrxHis-PZJ5 in E. coli. The transformation of all plasmids was carried out in E. coli, confirmed by DNA sequencing, and subsequently transformed for protein expression into E. coli BL21 (DE3).
Expression of Trx-His-tagged fused PZJ5 in E. coli: E. coli BL21 (pET32a-PZJ5) was culture overnight, followed by inoculation into 100 mL of LB broth containing ampicillin (100 μg/mL). When culturing to an OD 600 of 0.4, Isopropyl-β-D-thiogalactopyranoside (IPTG) was added to a final concentration of 1 mM and incubated for an additional 10 hours. The cell pellet was isolated by centrifugation and stored at -20°C until required.
SDS-PAGE and immunoblotting of Trx-His fusion protein:
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) was used to measure the molecular mass of the target protein, according to a previously published method [14] . The procedure was performed with a Mini-Protean electrophoresis system, according to the manufacturer's recommendations (BioRad, Hercules, CA, USA). A 15% SDS-PAGE gel was used to separate proteins at 150 V for 2 h, stained with Coomassie brilliant blue R250 (Bio-Rad), and washed with distilled and deionized H 2 O. This was followed by observation of protein bands blotting of the gel onto a nitrocellulose membrane (Amersham Biosciences, Piscataway, NJ, USA) to verify whether the antimicrobial peptide band was present. The primary antibody used was Anti-His tag mouse monoclonal antibodies (Sangon), as well as a goat antimouse horseradish peroxidase-conjugated secondary antibody (Sangon), detected via chemiluminescence (Sangon).
Purification of biologically active PZJ5: Affinity chromatography was used to isolate the fusion proteins from bacterial lysates with His Trap HP (GE Healthcare, Uppsala, Sweden). IPTG-induced cells in a 50 mL culture were centrifuged at 8000 g for 6 min at 4°C, followed by thawing on ice for 15 min, and re-suspended in 4 mL of phosphate-buffered saline (PBS). To lyse cells, lysozyme (1 mg/mL) was then added and the solution was incubated on ice for 30 min, followed by 10 min of sonication with breaks of 10 s under native conditions. The mixture was centrifuged at 12,000 g for 15 min, and the supernatant was collected, loaded onto the His Trap HP column, and rinsed twice in PBS (pH 7.4). Enterokinase was utilized to cleave the fusion protein, following the manufacturer's recommendations, and thereby recover the biologically active PZJ5 from Trx-His-fused PZJ5.
Antimicrobial peptide activity assay:
A basic procedure based on the agar diffusion test was carried out to observe the biological activity of purified protein. Indicator strain Micrococcus luteus (M. Luteus) was seeded on a LB soft agar overlay and 100 µL of the purified recombinant protein was inserted into a small hole in the overlay. Plates were incubated at 37°C. Antimicrobial activity was observed after 16 h as an inhibition halo around the recombinant protein sample within the bacterial lawn of M. luteus. Antimicrobial peptide activity was stipulated as the reciprocal of the highest twofold dilution that exerts inhibitory activity against the indicator strain and expressed in arbitrary units (AU) per milliliter.
